Vitamin D, Cardiovascular Disease, and African Americans
Maneno muhimu
Kikemikali
Maelezo
This study will be a double blinded, randomized controlled trial of vitamin D3 supplementation, 4,000 international units per day versus 600 international units per day, for one year to determine the effects on markers of subclinical cardiovascular disease in African Americans with type 2 diabetes and vitamin D deficiency. Outcome assessment will focus on changes in carotid intima-medial thickness (CIMT - ultrasound of the thickness of blood vessels in the neck), as well as markers of systemic inflammation.
Tarehe
Imethibitishwa Mwisho: | 05/31/2020 |
Iliyowasilishwa Kwanza: | 07/18/2012 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 07/31/2012 |
Iliyotumwa Kwanza: | 08/01/2012 |
Sasisho la Mwisho Liliwasilishwa: | 06/02/2020 |
Sasisho la Mwisho Lilichapishwa: | 06/04/2020 |
Tarehe halisi ya kuanza kwa masomo: | 08/12/2012 |
Tarehe ya Kukamilisha Msingi iliyokadiriwa: | 02/08/2018 |
Tarehe ya Kukamilisha Utafiti: | 02/08/2018 |
Hali au ugonjwa
Uingiliaji / matibabu
Dietary Supplement: Vitamin D 4000 IU
Dietary Supplement: Vitamin D 600 IU
Dietary Supplement: Calcium carbonate
Awamu
Vikundi vya Arm
Mkono | Uingiliaji / matibabu |
---|---|
Active Comparator: Vitamin D 4000 IU PO daily | Dietary Supplement: Vitamin D 4000 IU Multivitamin containing cholecalciferol 4000 units orally daily |
Active Comparator: Vitamin D 600 IU PO daily | Dietary Supplement: Vitamin D 600 IU Multivitamin containing cholecalciferol 600 units orally daily |
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 50 Years Kwa 50 Years |
Jinsia Inastahiki Kujifunza | All |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - African Americans of both genders - Age 50-70 years - Type 2 diabetes (A1C < 9.0%), on stable therapy with oral medications, insulin, or a combination - 25(OH)D level < 20 ng/ml - BP < 140/90 mmHg; LDL < 140 mg/dl Exclusion Criteria: - Pregnancy - Cardiovascular disease - Stage 3 or worse chronic kidney disease - High urine or serum calcium or history of recurrent kidney stones - Unstable medical conditions or major systemic diseases such as malignancy |
Matokeo
Hatua za Matokeo ya Msingi
1. Change from baseline in carotid intima-medial thickness [0, 6, and 12 months]
Hatua za Matokeo ya Sekondari
1. Change from baseline in systemic inflammatory markers [0, 6, and 12 months]
2. Serum calcium [0, 1, 3, 6, 9, and 12 months]
3. Urinary Calcium [0, 1, 3, 6, 9, and 12 months]